ACMG Variant Classification Scale: Understanding Genetic…

What is the ACMG/AMP Variant Classification System?

The American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) have developed a standardized framework for classifying genetic variants. This system categorizes each variant into one of five clinical tiers based on its potential impact on disease risk, aiding clinicians in making informed decisions about patient care.

The classification is crucial for guiding diagnostic testing, treatment options, and genetic counseling. It ensures that patients receive the most appropriate medical interventions and reduces unnecessary or harmful procedures.

How Does the 2D Bayesian Model Work?

The interactive 2D Bayesian ACMG/AMP variant classification scale uses a probabilistic approach to balance pathogenic (PS1-4) and benign (PM1-6, BS1-4) evidence criteria. By adjusting sliders for each type of criterion and the prior probability, users can visualize how these factors influence the posterior probability of a variant being disease-causing.

The Bayesian model updates in real-time as you modify the input parameters, providing an intuitive way to understand the complex interplay between different types of genetic evidence.

live demo · related simulation● LIVE

Why Use a 2D View for Classification?

A 2D view allows users to easily manipulate multiple criteria simultaneously. By rotating the scale's viewing angle, you can see how changes in one criterion affect the overall classification and posterior probability of a variant.

This interactive approach enhances understanding and decision-making by providing a dynamic representation of the classification process.

Real-World Applications

The ACMG/AMP variant classification system is widely used in clinical genetics to interpret next-generation sequencing (NGS) results. It helps genetic counselors and clinicians prioritize variants for further investigation, ensuring that patients receive the most relevant and effective care.

By applying this framework, healthcare providers can make evidence-based decisions about genetic testing, diagnosis, and treatment strategies.

Frequently asked questions

What is PVS1 in ACMG/AMP classification?

PVS1 refers to a very strong criterion that indicates the variant is likely pathogenic. It is one of the most definitive pieces of evidence for classifying a variant as disease-causing.

How does the Bayesian prior probability affect the classification?

The Bayesian prior probability represents the initial likelihood of a variant being disease-causing before considering any specific evidence. It influences how much weight is given to pathogenic and benign criteria in the final classification.

Can I use this tool for all types of genetic variants?

The ACMG/AMP system is primarily designed for single nucleotide variants (SNVs) and small insertions/deletions (indels). It may not be suitable for larger structural variations or copy number changes.

Is the 2D model accurate for all genetic conditions?

While the ACMG/AMP system provides a structured approach, its accuracy depends on the quality and quantity of evidence available. The 2D Bayesian model helps in making more informed decisions but should be used in conjunction with clinical judgment.

Try it live

Everything above runs in your browser — open ACMG Variant Classification Scale (2D) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open ACMG Variant Classification Scale (2D) simulation

ACMG Variant Classification Scale: Understanding Genetic Evidence for Disease